Gut inflammation is associated with aging and Alzheimer’s disease (AD), according to a study published in Scientific Reports. The study found that as people age, their gut microbiome changes, leading to more inflammation and a higher risk of barrier breakdown. This inflammation may feed into cognitive impairment and AD progression. Further research is required to confirm these findings and potentially identify new methods of AD prevention.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
